NASDAQ:OBIO | Free Cash Flow | Orchestra BioMed Holdings, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$22.17M$184,000.00-$22.35M
2025-12-31-$2.27M$33,000.00-$2.3M-36.88%
2025-03-31-$16.62M$112,000.00-$16.73M
2024-12-31-$13.54M$106,000.00-$13.64M
2024-03-31-$13.11M$8,000.00-$13.12M
2023-12-31-$10.97M-$3,000.00-$10.98M
2023-03-31-$14.38M$35,000.00-$14.42M
2022-12-31-$8.74M$54,000.00-$8.8M
2022-03-31-$5.32M$47,000.00-$5.37M
2021-12-31-$28,835.00
2021-03-31-$76,374.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$48.96M$489,000.00-$49.45M
2024-12-31-$50.56M$289,000.00-$50.85M
2023-12-31-$46.13M$78,000.00-$46.21M
2022-12-31-$29.29M$591,000.00-$29.88M
2021-12-31-$272,362.00